Singlera

Singlera (鹍远生物), founded in 2014, is a leader in DNA methylation-based tumor molecular testing in China. The company develops proprietary DNA methylation technology platforms and a comprehensive product portfolio covering the entire cancer care cycle, from early detection and diagnosis to recurrence prediction and monitoring. Its pipeline addresses multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers. Singlera operates R&D centers in Shanghai and San Diego, production bases in Yangzhou and Wuxi, and a medical testing laboratory in Taizhou, with service points across more than 100 cities in China.

Singlera was founded in 2014. It has since become a leader in DNA methylation-based tumor molecular testing in China, focusing on cancer early screening and liquid biopsy. The company has developed proprietary DNA methylation technology platforms and a comprehensive product portfolio covering the entire cancer care cycle. It has participated in multiple national major scientific research projects and collaborated with top academic institutions, hospitals, and pharmaceutical companies. Key milestones include the 2025 registration approval of ColonAiQ® by Singapore's Health Sciences Authority (HSA) and Thailand's Food and Drug Administration (FDA), and the publication of multiple research findings in journals such as Molecular Cancer and Biomarker Research.

Leader in cancer early screening and liquid biopsy in China, focused on DNA methylation-based tumor molecular testing.

• 常艾克® (ColonAiQ®)

  Colorectal cancer blood multi-gene methylation combined detection kit.

• Fecal Occult Blood/Transferrin Combined Detection Kit (Colloidal Gold Method)

  In vitro diagnostic reagent.

• Helicobacter pylori Antigen Detection Kit (Colloidal Gold Method)

  In vitro diagnostic reagent.

• Nucleic Acid Extraction or Purification Reagent

  In vitro diagnostic reagent.

• Methylation Detection Sample Pretreatment Reagent

  In vitro diagnostic reagent.

• CaptureRevo NAE24 Nucleic Acid Extractor

  In vitro diagnostic instrument.

• Fecal Occult Blood Detection Kit (Colloidal Gold Method)

  In vitro diagnostic reagent.

• Fecal Occult Blood/Calprotectin Combined Detection Kit (Colloidal Gold Method)

  In vitro diagnostic reagent.

• HepaAiQ® / 甘艾克®

  Liver cancer blood multi-gene methylation detection technology (in research pipeline).

• PDACatch™

  Pancreatic cancer blood multi-gene methylation early detection technology (in research pipeline).

• GutSeer®

  Digestive system five-cancer blood multi-gene methylation detection technology (in research pipeline).

• PanSeer®

  Multi-cancer blood multi-gene methylation early detection technology (in research pipeline).

1. 1鹍远生物：引领癌症早筛和液体活检singlera.com.cn
2. 2企业简介 - 关于鹍远 - 鹍远生物singlera.com.cn
3. 3体外诊断试剂及仪器 - 产品管线 - 鹍远生物singlera.com.cn
4. 4在研产品管线 - 产品管线 - 鹍远生物singlera.com.cn
5. 5Singlera (China)wikidata.org